Abstract
Objective
This study compared operative mortality and morbidity based on the number of previous cardiac operations to identify whether this was a risk factor for outcomes after valve reoperation.
Methods
Among valve surgery patients in the Japan Cardiovascular Surgery Database (2013‒2015), 4436 patients who underwent valve reoperation with a previous cardiac surgery were included. Patients were divided into three groups based on the number of previous cardiac operations (NPO1, NPO2, and NPO3+). Multivariable logistic regression analyses were conducted, adjusting for patient- and surgery-related factors to estimate the association of the NPO with the clinical outcomes of valve reoperation.
Results
Postoperative mortality was 8.6% in the NPO1, 11.2% in the NPO2, and 14.4% in the NPO3 + group, and the corresponding postoperative morbidity rates were 40.0, 46.2, and 59.2%, respectively. On multivariable logistic regression analysis, the odds of operative death were 1.36 (95% confidence interval [CI] 0.98‒1.87, p = 0.06) times higher for the NPO2 and 1.61 (95% CI 0.89‒2.90, p = 0.11) times higher for the NPO3+ group than for the NPO1 group. The odds ratios for postoperative complications were 1.31 (95% CI 1.08‒1.59, p < 0.01) for the NPO2 and 2.49 (95% CI 1.66‒3.74, p < 0.01) for the NPO3+ relative to the NPO1 group.
Conclusion
The number of previous cardiac operations is associated with postoperative outcomes in patients undergoing valve reoperations. Considering the risk of repeat cardiac surgery, we recommend careful selection of operative procedures to avoid reoperation in patients requiring primary valve surgery.
Similar content being viewed by others
References
Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, Shimizu H, Okada M, Toh Y, Doki Y, Endo S, Fukuda H, et al. Thoracic and cardiovascular surgeries in Japan during 2018: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2021;69:179–212.
Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, Shimizu H, Okada M, Tangoku A, Doki Y, Endo S, Fukuda H, et al. Thoracic and cardiovascular surgeries in Japan during 2017: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2020;68:414–49.
Launcelott S, Ouzounian M, Buth KJ, Légaré JF. Predicting in-hospital mortality after redo cardiac operations: development of a preoperative scorecard. Ann Thorac Surg. 2012;94:778–84.
Bridges CR, Edwards FH, Peterson ED, Coombs LP, Ferguson TB. Cardiac surgery in nonagenarians and centenarians. J Am Coll Surg. 2003;197:347–56 (discussion 356–57).
Ngaage DL, Cowen ME, Griffin S, Guvendik L, Cale AR. The impact of symptom severity on cardiac reoperative risk: early referral and reoperation is warranted. Eur J Cardiothorac Surg. 2007;32:623–8.
O’Brien SM, Feng L, He X, Xian Y, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons 2018 adult cardiac surgery risk models: Part 2—statistical methods and results. Ann Thorac Surg. 2018;105:1419–28.
Tatsuishi W, Kumamaru H, Nakano K, Miyata H, Motomura N. Evaluation of postoperative outcomes of valve reoperation: a retrospective study. Eur J Cardiothorac Surg. 2021;59:869–77.
Usui A, Miyata H, Ueda Y, Motomura N, Takamoto S. Risk-adjusted and case-matched comparative study between antegrade and retrograde cerebral perfusion during aortic arch surgery: based on the Japan Adult Cardiovascular Surgery Database. Gen Thorac Cardiovasc Surg. 2012;60:132–9.
Ghoreishi M, Dawood M, Hobbs G, Pasrija C, Riley P, Petrose L, et al. Repeat sternotomy: no longer a risk factor in mitral valve surgical procedures. Ann Thorac Surg. 2013;96:1358–65.
Maganti M, Rao V, Armstrong S, Feindel CM, Scully HE, David TE. Redo valvular surgery in elderly patients. Ann Thorac Surg. 2009;87:521–5.
Davierwala PM, Borger MA, David TE, Rao V, Maganti M, Yau TM. Reoperation is not an independent predictor of mortality during aortic valve surgery. J Thorac Cardiovasc Surg. 2006;131:329–35.
Tourmousoglou C, Rao V, Lalos S, Dougenis D. What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement? Interact Cardiovasc Thorac Surg. 2015;20:837–43.
Park CB, Suri RM, Burkhart HM, Greason KL, Dearani JA, Schaff HV, et al. Identifying patients at particular risk of injury during repeat sternotomy: analysis of 2555 cardiac reoperations. J Thorac Cardiovasc Surg. 2010;140:1028–35.
Ataka K, Okada M, Yamashita C, Yamashita T, Wakiyama H, Nakagiri K, et al. Valvular heart disease. A comparative study of results after primary operation, reoperation, and after multiple reoperation. Jpn J Thorac Cardiovasc Surg. 1999;47:377–82.
Toker ME, Eren E, Guler M, Kirali K, Yanartas M, Balkanay M, et al. Second and third cardiac valve reoperations: factors influencing death and long-term survival. Tex Heart Inst J. 2009;36:557–62.
Sohn SH, Hwang HY, Kim KH, Kim KB, Ahn H. Surgical results of third or more cardiac valve operation. Korean J Thorac Cardiovasc Surg. 2015;48:25–32.
Pansini S, Ottino G, Forsennati PG, Serpieri G, Zattera G, Casabona R, et al. Reoperations on heart valve prostheses: an analysis of operative risks and late results. Ann Thorac Surg. 1990;50:590–6.
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2021;77:e25–197.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021;60:727–800.
Izumi C, Eishi K, Ashihara K, Arita T, Otsuji Y, Kunihara T, et al. JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease. Circ J. 2020;84:2037–119.
Sathananthan J, Hensey M, Landes U, Alkhodair A, Saiduddin A, Sellers S, et al. Long-term durability of transcatheter heart valves: insights from bench testing to 25 years. JACC Cardiovasc Interv. 2020;13:235–49.
Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol. 2019;73:537–45.
Sedeek AF, Greason KL, Sandhu GS, Dearani JA, Holmes DR Jr, Schaff HV. Transcatheter valve-in-valve vs surgical replacement of failing stented aortic biological valves. Ann Thorac Surg. 2019;108:424–30.
Panico RA, Giannini C, De Carlo M, Angelillis M, Spontoni P, Pieroni A, et al. Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years. EuroIntervention. 2019;14:1639–47.
El Faquir N, Ren B, Faure M, de Ronde M, Geeve P, Maugenest AM, et al. Long-term structural integrity and durability of the Medtronic CoreValve System after transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2018;11:781–3.
Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Roselli EE, Sabik JF 3rd, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99:1239–47.
Harloff MT, Chowdhury M, Hirji SA, Percy ED, Yazdchi F, Shim H, et al. A step-by-step guide to transseptal valve-in-valve transcatheter mitral valve replacement. Ann Cardiothorac Surg. 2021;10:113–21.
Acknowledgements
We thank Dr. Takamoto for his support in the governance and management of the JCVSD.
IRB information: The study was approved by The Institutional Review Board of Gunma University Hospital (No. HS2020-235).
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tatsuishi, W., Kumamaru, H., Abe, T. et al. Postoperative outcomes of valve reoperation are associated with the number of previous cardiac operations. Gen Thorac Cardiovasc Surg 70, 939–946 (2022). https://doi.org/10.1007/s11748-022-01828-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-022-01828-0